Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Neoplasms, Plasma Cell 14Lymphoma 14Leukemia 13Burkitt Lymphoma 10Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 5HIV Infections 5Brain Neoplasms 5Acquired Immunodeficiency Syndrome 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Leukemia, Biphenotypic, Acute 4Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Rectal Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Chronic 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Diseases 2Down Syndrome 2Dendritic Cell Sarcoma, Interdigitating 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anemia, Refractory, with Excess of Blasts 2

Interventions

tanespimycin 4fludarabine phosphate 4Magnetic Resonance Spectroscopy 4Cyclosporine 4Biopsy 4romidepsin 3aldesleukin 3Vorinostat 3Specimen Handling 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Irinotecan 3Gemcitabine 3Flow Cytometry 3Bortezomib 3pembrolizumab 2nelarabine 2mogamulizumab 2laromustine 2fludarabine 2entinostat 2belinostat 2alvocidib 2Psychiatric Rehabilitation 2Pharmacogenomic Testing 2Nivolumab 2Methylprednisolone 2MK 2206 2Levofloxacin 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Mycosis Fungoides × Dexamethasone × Clear all
NCT00006345 2013-05-30

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡